An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't ...

An interview with former White House communications strategist Andrew Bates, who explains how Democrats can capitalize on ...

Manufacturers are responsible for meeting all four parts of the definition of bona fide service fee before a fee can qualify as a bona fide ...

Speaker Mike Johnson (R-La.) indicated this week that his approach to repealing the Democrats’ climate, tax, infrastructure ...

At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...

Patient advocacy group Patients for Affordable Drugs (P4AD) yesterday filed its fourth amicus brief defending the Biden ...

The bipartisan group of North Carolina U.S. lawmakers have introduced a bill they say fixes the Inflation Reduction Act's ...

Prior authorization reforms, increased biosimilar access and the future of the Medicare drug price negotiation program are ...

The purpose of the Affordable Care Act (ACA) was to make healthcare more affordable. It has had various effects on Medicare, ...

The bill would allow Medicare to begin negotiating with pharmaceutical companies over prices for small molecule medicines 13 ...

A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more ...